Eterobarb (Antilon) is a barbiturate derivative. It has mainly anticonvulsant action with less sedative effects than the closely related compound phenobarbital. It saw reasonable success in clinical trials, but is not in widespread medical use.[1][2]
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C16H20N2O5 |
Molar mass | 320.345 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Eterobarb can be synthesized by reacting phenobarbital with chloromethyl methyl ether in presence of a base.[3]